Neuro-Oncology Practice
Published by Oxford University Press
ISSN : 2054-2577 eISSN : 2054-2585
Abbreviation : Neuro-oncology Pract.
Aims & Scope
Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice.
These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 2.5 |
| 2024 | 2.40 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.901 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q2 |
h-index
| Year | Value |
|---|---|
| 2024 | 34 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 5690 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 490 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians
Citation: 66
Authors: Justin T, Quinn T, Gino, Corey, Kristin A, Carol, Jill S
-
Management of low-grade glioma: a systematic review and meta-analysis
Citation: 50
Authors: Timothy J, Daniela A, Martin J, Paul D, Elizabeth, Dawit, Linda M, Jan C, Michael, Mitchel S, Michael
-
Existential distress among caregivers of patients with brain tumors: a review of the literature
Citation: 48
Authors: Allison J., Maria, Justin, Antonio, Geoff, Eli L.
-
Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma
Citation: 45
Authors: Karin, Martin J.B., Margriet M., Neil K.
-
The cIMPACT-NOW updates and their significance to current neuro-oncology practice
Citation: 44
Authors: L Nicolas, Pieter
-
Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a retrospective cohort study prior to antitumor treatment
Citation: 44
Authors: Emma, Michelle A C, Irene H, Kirsten M, Marike L, Pierre A, Tom J, Martine J E
-
Impact of mass effect, tumor location, age, and surgery on the cognitive outcome of patients with high-grade gliomas: a longitudinal study
Citation: 43
Authors: Monica, Silvio, Stefano, Francesco, Giuseppe, Umberto, Mattia, Franco
-
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation
Citation: 43
Authors: Katrina A., John F., Patrick R., Shazia, Claire, Rosalie E., Dorothy, Raj, Pieter M., D. Gareth, Martin G., Allyson